0.5951

2.72% -0.0217

Cdt Equity Inc (CDT)

Überblick Nachrichten Preisverlauf Warum fällt CDT? Forum Prognose

Schlusskurs vom Vortag:

$0.6168

Offen:

$0.6

24-Stunden-Volumen:

39,847

Relative Volume:

0.06

Marktkapitalisierung:

$8.15M

Einnahmen:

Nettoeinkommen (Verlust:

$-39.62M

KGV:

-0.00036

EPS:

-1654.3275

Netto-Cashflow:

$-17.96M

1W Leistung:

-34.07%

1M Leistung:

-82.46%

6M Leistung:

-99.65%

1J Leistung:

-99.95%

1-Tages-Spanne:

$0.5801

$0.6167

1-Wochen-Bereich:

$0.5801

$0.8855

52-Wochen-Spanne:

$0.5801

$2,360.00

Cdt Equity Inc Stock (CDT) Company Profile

Firmenname

Cdt Equity Inc

Sektor

Healthcare (1087)

Branche

Biotechnology (606)

Telefon

(646) 491 9132

Adresse

4851 TAMIAMI TRAIL NORTH, NAPLES

Mitarbeiter

Twitter

Nächster Verdiensttermin

2026-08-13

Neueste SEC-Einreichungen

CDT's Discussions on Twitter

Compare CDT vs VRTX, REGN, ARGX, MRNA, RVMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
CDT Cdt Equity Inc	0.5951	8.45M	0	-39.62M	-17.96M	-1,654.33
VRTX Vertex Pharmaceuticals Inc	522.40	134.06B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	803.89	83.43B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,003.53	63.00B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	138.23	56.02B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	209.36	44.44B	742.00K	-1.37B	-1.07B	-7.0731

Cdt Equity Inc Aktie (CDT) Neueste Nachrichten

Sep 06, 2026

CDT Equity Amends $8 Million Sarborg Investment and Adds $542K Convertible Note, Later Repaid - TradingView

Sep 04, 2026

Sep 03, 2026

CDT Equity Inc. announced that it has received $1.46 million in funding from J.J. Astor & Co. - marketscreener.com

Sep 03, 2026

These stocks are moving in today's after hours session - ChartMill

Sep 03, 2026

Corvus Capital's Activist Stake in CDT Equity (NASDAQ: CDT) Reaches 43.7% - kalkinemedia.com

Sep 03, 2026

Corvus Capital Converts CDT Equity (NASDAQ: CDT) Warrants into 5.44 Million Common Shares, Holding 43.7% Stake - Kalkine Media

Sep 03, 2026

Cdt equity CEO Andrew Regan’s entity acquires shares, disposes of 290 - Investing.com

Sep 03, 2026

Sep 02, 2026

Nearly 10% of CDT Equity Inc. (CDT) is reported in one shareholder group’s hands - Stock Titan

Sep 02, 2026

[Form 4] CDT Equity Inc. Insider Trading Activity - Stock Titan

Sep 02, 2026

[SCHEDULE 13D/A] CDT Equity Inc. Amended Major Shareholder Report - Stock Titan

Sep 02, 2026

CDT Equity Share Issuance Boosts Nasdaq Compliance Status - The Globe and Mail

Sep 02, 2026

Dow Surges Over 200 Points; Ollie's Bargain Outlet Shares Gain After Q2 Earnings - Benzinga

Sep 02, 2026

CDT Equity (NASDAQ: CDT) Achieves $23 Million Market Cap Following Full Warrant Conversion - Kalkine Media

Sep 02, 2026

CDT Equity Names James Bligh CEO Amid Leadership Shift - The Globe and Mail

Sep 02, 2026

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Sep 02, 2026

CDT Equity Inc. Reports 13.7 Million Shares Outstanding and Nasdaq Compliance - Quiver Quantitative

Sep 02, 2026

CDT Provides Capital Update and Confirms No Nasdaq Deficiencies - The Manila Times

Sep 02, 2026

CDT Equity (CDT) Shares Fall 21% After Hours: Here's What Happened - Benzinga

Sep 02, 2026

Sep 01, 2026

12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga

Sep 01, 2026

James Bligh Appointed CEO of CDT Equity (NASDAQ: CDT) Starting August 31 with $600,000 Salary - Kalkine Media

Sep 01, 2026

CDT Appoints Co-Founder James Bligh as Chief Executive Officer to Lead Next Phase of Growth - The Manila Times

Sep 01, 2026

CDT Equity appoints James Bligh as CEO; Andrew Regan resigns - TradingView

Sep 01, 2026

CDT Equity names CEO, gets reverse split approval - Stock Titan

Sep 01, 2026

CDT Equity Inc. Announces Resignation of Andrew Regan from the Board, Effective August 31, 2026 - marketscreener.com

Sep 01, 2026

Aug 31, 2026

CDT Validates Enhanced Solid-Form Properties within Its IP Portfolio - marketscreener.com

Aug 31, 2026

Aug 28, 2026

CDT Validates Enhanced Solid-Form Properties Within Its IP Portfolio - The Manila Times

Aug 28, 2026

CDT Equity Inc. Announces New Patent-Protected Solid Forms and AI-Identified Uses for Existing Drug Compounds - Moomoo

Aug 28, 2026

CDT's new drug-compound forms show improved stability and solubility - Stock Titan

Aug 28, 2026

Aug 26, 2026

CDT (CDT) Results Review: The Company Publishes Its Latest Results on the Day; Stock Move: The Stock Ends Down 18.32% in the Available RecordEarnings Beat Streak - dars.gov.et

Aug 26, 2026

Aug 25, 2026

Pep?d Inc. announced that it has received funding from CDT Equity Inc. - marketscreener.com

Aug 25, 2026

CDT Announces Investment in Pep'd, Expanding into the Fast-Growing US Peptide Market - The Manila Times

Aug 25, 2026

The global peptide therapeutics market is projected to reach $294.6B by 2033; CDT invests in Pep'd - Stock Titan

Aug 25, 2026

Aug 22, 2026

Enterprise value to revenue forward of CDT Equity Inc. – NASDAQ:CDTTW - TradingView

Aug 22, 2026

CDT (CDT) Chart: Falls 1.38% to $2.86 in Latest Trading; Immediate View: the Session Ends Within the Reported Technical Boundaries in the Available RecordMAMA Signal - vinanet.vn

Aug 22, 2026

Aug 21, 2026

Passive 2.97% stake by investor group in CDT Equity (CDT) - Stock Titan

Aug 21, 2026

New 5.3% passive stake surfaces in CDT Equity Inc. (CDT) - Stock Titan

Aug 21, 2026

12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga

Aug 21, 2026

CDT Equity (CDT) Sarborg losses, $65M patents and going‑concern doubts - Stock Titan

Aug 21, 2026

Aug 17, 2026

CDT | CDT Equity Inc. Common Executive Compensation - Quiver Quantitative

Aug 17, 2026

Aug 12, 2026

CDT Equity Inc. Q2 2026: Net loss $(4.64M), EPS $(8.71) — 10-Q Summary - TradingView

Aug 12, 2026